Diabetes Associated With Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype

Area of Science:

• Mitochondrial genetics
• Endocrinology
• Genetics

Background:

• Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disorder.
• The m.3243A>G mutation is the most common cause of MIDD, leading to hearing loss and diabetes.
• MIDD involves complex cellular changes affecting both mitochondrial and nuclear gene expression.

Purpose of the Study:

• To elucidate the mechanisms underlying Maternally inherited diabetes and deafness (MIDD).
• To understand the role of specific heteroplasmy levels in disease pathogenesis.
• To provide a basis for developing targeted management strategies for MIDD.

Main Methods:

• Analysis of m.3243A>G mutation heteroplasmy in skeletal muscle and other cells.
• Assessment of insulin resistance and beta-cell function.
• Correlation of heteroplasmy levels with clinical phenotypes.

Main Results:

• MIDD pathogenesis is linked to high skeletal muscle heteroplasmy (≥60%) and moderate cellular heteroplasmy (25%-72%) for the m.3243A>G mutation.
• These heteroplasmy levels are associated with a combination of insulin resistance and impaired beta-cell function.
• The study highlights complex cellular rewiring and genome expression remodeling in MIDD.

Conclusions:

• MIDD is driven by specific thresholds of m.3243A>G heteroplasmy.
• Understanding these mechanisms is crucial for developing effective, disease-specific treatments.
• Current management guidelines for MIDD are lacking and require development based on these findings.